natesto gel
acerus biopharma inc - testostérone - gel - 4.5% - testostérone 4.5% - androgens
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - la vildagliptine, la metformine chlorhydrate de - diabète sucré, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).
xiliarx
novartis europharm limited - vildagliptine - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).
conforma hydrocortisone 10 mg/g crème
conforma sa-nv - acétate d'hydrocortisone 10 mg/g - crème - 10 mg/g - acétate d'hydrocortisone 10 mg/g - hydrocortisone
galvus
novartis europharm limited - vildagliptine - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptine - diabète sucré, type 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).
aqua cuprozincica conforma 7,65 mg/ml - 25,5 mg/ml sol. cut.
conforma sa-nv - sulfate de zinc heptahydraté - eq. sulfate de zinc 25 mg/g; sulfate de cuivre 7,65 mg/ml - solution pour application cutanée - 7,65 mg/ml - 25,5 mg/ml - sulfate de cuivre 7.65 mg/ml; sulfate de zinc heptahydraté - antiseptics and disinfectants
sirop à la codéine au goût d'eucalyptol conforma 2,67 mg/ml sirop
conforma sa-nv - codéine 2,67 mg/ml - sirop - 2,67 mg/ml - codéine 2.67 mg/ml - opium alkaloids and derivatives
sirop à la codéine au goût d’eucalyptol conforma 2,67 mg/ml sirop
conforma sa-nv - codéine 2,67 mg/ml - sirop - 2,67 mg/ml - codéine 2.67 mg/ml - opium alkaloids and derivatives
embrocatio conforma 40 mg/g - 70 mg/g émuls. cut.
conforma sa-nv - pinus pinaster aiton, résine, huile essentielle 70 mg/g; camphre synthétique 40 mg/g - emulsion cutanée - 40 mg/g - 70 mg/g - turpentine huile 70 mg/g; camphre 40 mg/g - various